Glickman Urological & Kidney Institute Outcomes
Surgical Quality Improvement
Prostatectomy Outcomes
Prostatectomy ACS NSQIP Outcomes
January 1, 2024 – December 31, 2024
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s prostatectomy ACS NSQIP performance benchmarked against 119 participating sites.
| Prostatectomy (119 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Morbidity | 154 | 6.49% | 6.03% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 154 | 0.00% | 0.58% |
| Renal Failure | 154 | 1.30% | 0.50% |
| Urinary Tract Infection (UTI) | 154 | 2.60% | 2.56% |
| Surgical Site Infection (SSI) | 154 | 1.95% | 2.14% |
| Sepsis | 154 | 0.00% | 0.28% |
| Unplanned Reoperation | 154 | 0.65% | 0.56% |
| Unplanned Readmission | 154 | 7.79% | 3.45% |
| Rectal Injury | 154 | 0.00% | 0.31% |
| Prolonged NPO/NGT Use | 154 | 1.30% | 0.45% |
| Ureteral Obstruction | 154 | 0.00% | 0.12% |
| Urinary Leak/Fistula | 154 | 0.00% | 0.80% |
| Lymphocele/Leak/Fluid | 154 | 1.95% | 1.55% |
American College of Surgeons National Surgical Quality Improvement Program, 2025.
ACS NSQIP® Semiannual Report July, 2025, Chicago: American College of Surgeons.
